Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Earning money while studying is possible with the right strategies. Explore various ways to balance work and academics.
27,524 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Iran asserts a new permission and insurance framework for crossing the Strait of Hormuz, while ships continue to move...
With rates stabilizing in the mid-6% range, the housing market braces for a steadier second half of 2026. Pending sal...
After a string of near-misses, Netflix finally makes acquisition that seems to align with its long-term plan. This pi...
Ethereum clawed back from a dip toward $1.5K, but the longer-term trend remains bearish even as buyers defend a criti...
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Micron’s shares fell about 12% at the open amid a broad market rout. Yet analysts see a longer-term memory shortage d...
A security advisory from Ethereum L2 Taiko warns users to pull funds from Taiko-linked bridges after a state verifica...
As AI infrastructure expands, storage demand soars. This article lays out a grounded path for Sandisk's stock by 2027...
Oil around $75 invites questions about ConocoPhillips stock. This guide breaks down how to assess COP, weigh oil sens...
Microsoft’s stock has fallen out of step with broader AI enthusiasm as Copilot results lag and cloud growth cools, le...
A TD Cowen analyst floated SpaceX purchasing T-Mobile, turning heads in investing circles as markets weigh strategic ...